Axis Direct
We expect revenue and PAT CAGR of 15.9% and 15.3% respectively over the period FY21-FY23E and recommend a Buy with TP of INR 840.
Aarti Drugs Ltd. has lost -10.55% in the last 1 Week
More from Aarti Drugs Ltd.
Recommended